Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In Canada, no unified national guideline exists for the front-line treatment of cll; provincial guidelines vary and are largely based on funding. A group of clinical experts from across Canada developed a national evidence-based treatment guideline to provide health care professionals with clear guidance on the first-line management of cll. Consensus recommendations based on available evidence are presented for the first-line treatment of cll.

authors

  • Owen, C
  • Gerrie, AS
  • Banerji, V
  • Assouline, S
  • Chen, C
  • Robinson, KS
  • Lye, E
  • Fraser, Graeme

publication date

  • October 2018